Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 4:33 pm |
N/A 2035-02-28 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE President and CEO |
140,103 | $0 | 140,103 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-06 4:23 pm |
N/A 2034-09-04 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
33,920 | $0 | 33,920 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:41 pm |
N/A 2024-03-01 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
965,435 | $0 | 965,435 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:32 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
421,100 | $0 | 421,100 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
2023-10-25 2030-10-25 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
305,138 | $0.125 | 2,425,771 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
610,277 | $0.7568 | 2,425,771 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:05 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:09 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
242,500 | $0 | 242,500 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:13 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
161,700 | $0 | 161,700 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:09 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
404,250 | $0 | 404,250 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 8:03 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 4:55 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
273,058 | $0 | 1,255,815 (Indirect) |
View |
Ownership |
2020-10-15 5:09 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
0 | $0 | 2,368,752 (Direct) |
View |